Your current location: Homepage >  Products >  Products in R&D

Products

Scan pays attention to us

Products in R&D

The 8th National Conference on Gastric Cancer announced that 400,000 new cases of gastric cancer have been reported annually in China in the past five years, accounting for about 42% of the world's total incidence.Clinical data show that the effective cure of gastric cancer is closely related to the discovery of gastric cancer.The 5-year survival rate of early gastric cancer after operation can reach more than 95%, almost all of them can recover, but if it is found in the middle and late stage, the 5-year survival rate is less than 20%.In addition, such as acute and chronic gastritis, atrophic gastritis, ulcerative disease, ulcerative colitis and so on are also common diseases, frequently occurring, affecting and plaguing the health and quality of life of the people.

Traditional gastroscopy and enteroscopy are not well accepted because of the discomfort caused by the examination process. Over time, gastric diseases have been neglected.Early detection and treatment of diseases are crucial, for example, the prognosis of gastric cancer is significantly different from that of gastric cancer.

The Capsule Endoscopic Robot System Project is the first active control technology of Capsule Endoscopic Robot system in the world, which is a breakthrough in technique for the second-generation Capsule Endoscopic Robot in active control. In addition, it can significantly improve the effectiveness and credibility of the examination through accurate control and positioning, at the same time it is very convenient and fast for the examination for the stomach part, which is more comprehensive.